KF
LEXX icon

Krilogy Financial’s Lexaria Bioscience LEXX Stock Holding History

Krilogy Financial’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4K Hold
19,653
– – ﹤0.01% 969
2025
Q4 		$16K Hold
19,653
– – ﹤0.01% 919
2025
Q3 		$21.2K Buy
+19,653
New +$19K ﹤0.01% 861

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Krilogy Financial's LEXX Position: Q1 2026 in Review

Krilogy Financial held its Lexaria Bioscience (LEXX) position steady in Q1 2026 at 19,653 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #969.

Krilogy Financial first reported a position in LEXX in Q3 2025 and has held it in 3 quarters since. The position peaked at $21.2K in Q3 2025. 28 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Krilogy Financial held 19,653 shares of Lexaria Bioscience worth $19.4K as of Q1 2026.
  • Krilogy Financial left its Lexaria Bioscience share count unchanged in Q1 2026.
  • Lexaria Bioscience made up ﹤0.01% of Krilogy Financial's portfolio in Q1 2026, its #969 holding.
  • Krilogy Financial first reported a position in Lexaria Bioscience in Q3 2025 and has held it in 3 quarters since.
  • Krilogy Financial's Lexaria Bioscience position peaked at $21.2K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.